Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Merck
Boehringer Ingelheim
Dow
Johnson and Johnson

Last Updated: August 13, 2022

CLINICAL TRIALS PROFILE FOR THEOPHYLLINE-SR


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Theophylline-sr

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000575 ↗ Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed CAMP Steering Committee Phase 3 1991-09-01 The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗ Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1991-09-01 The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗ Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed Johns Hopkins Bloomberg School of Public Health Phase 3 1991-09-01 The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Theophylline-sr

Condition Name

Condition Name for Theophylline-sr
Intervention Trials
Asthma 22
Chronic Obstructive Pulmonary Disease 8
COPD 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Theophylline-sr
Intervention Trials
Asthma 20
Lung Diseases 18
Pulmonary Disease, Chronic Obstructive 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Theophylline-sr

Trials by Country

Trials by Country for Theophylline-sr
Location Trials
United States 138
China 24
Japan 19
Canada 13
United Kingdom 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Theophylline-sr
Location Trials
California 13
Colorado 11
Texas 9
Missouri 8
Tennessee 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Theophylline-sr

Clinical Trial Phase

Clinical Trial Phase for Theophylline-sr
Clinical Trial Phase Trials
Phase 4 19
Phase 3 19
Phase 2/Phase 3 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Theophylline-sr
Clinical Trial Phase Trials
Completed 67
Unknown status 14
Recruiting 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Theophylline-sr

Sponsor Name

Sponsor Name for Theophylline-sr
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 10
Boehringer Ingelheim 4
The First Affiliated Hospital of Guangzhou Medical University 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Theophylline-sr
Sponsor Trials
Other 117
Industry 30
NIH 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Baxter
McKesson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.